Implants and Injectables

September/October

Read Article
 

@GlaucomaToday

Visit @GlaucomaToday on Twitter

Articles From This Issue


 

Implants and Injectables

COVER FOCUS: Script Rewrite

During the past few years, there has been an incredible proliferation of technology in the pharmaceutical and surgical areas of glaucoma. The driving force behind these ad…

Is Glaucoma a Surgical Disease?

UP FRONT

Early in my medical career, I approached glaucoma predominantly as a medical disease. I typically started patients on a prostaglandin analogue or timolol as first-line tre…

The Literature

THE LITERATURE

Quality of Life in the Tube Versus Trabeculectomy Study Kotecha A, Feuer WJ, Barton K, Gedde SJ; Tube Versus Trabeculectomy Study Group1 ABSTRACT SUMMARY This mul…

 

GlaucomaToday Polls

View All

NEWS


 

ARC Laser Receives FDA Approval for Cetus Nano-Laser System

ARC Laser recently received FDA approval for the use of the Cetus Nano-Laser system in cataract surg…

Johnson and Johnson Vision to Introduce iDESIGN Refractive Studio at ESCRS

Johnson & Johnson Vision will introduce the new iDESIGN Refractive Studio and CATALYS Precision …

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.